Jay Warner - Nemaura Medical Head Operations

NMRDDelisted Stock  USD 0.93  0.01  1.06%   

Insider

Jay Warner is Head Operations of Nemaura Medical
Phone646 416 7912
Webhttps://nemauramedical.com

Nemaura Medical Management Efficiency

The company has return on total asset (ROA) of (0.4928) % which means that it has lost $0.4928 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.2444) %, meaning that it created substantial loss on money invested by shareholders. Nemaura Medical's management efficiency ratios could be used to measure how well Nemaura Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Nemaura Medical currently holds 20.03 M in liabilities. Nemaura Medical has a current ratio of 0.97, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nemaura Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Nemaura Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nemaura Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nemaura to invest in growth at high rates of return. When we think about Nemaura Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Jon SalvesonArtivion
56
Paul VerrastroCVRx Inc
61
Christopher LesovitzSTRATA Skin Sciences
41
Martha MorrellNeuropace
67
David MDNexalin Technology
62
Brad NagelElectromed
N/A
Jason CookBluejay Diagnostics
42
Kenneth CPABluejay Diagnostics
44
Kevin VanceBluejay Diagnostics
66
Andrew GreenArtivion
52
Robert MocciaSTRATA Skin Sciences
65
Craig GlynnenVVeno Medical Corp
63
Rebecca KuhnNeuropace
63
Robert BermanenVVeno Medical Corp
61
Darrell RigelSTRATA Skin Sciences
73
Joshua WellsArtivion
N/A
Mark QuickOrthofix Medical
N/A
Kevin SchmidModular Medical
65
Joel BradusNexalin Technology
N/A
Marshall StantonArtivion
64
Amy HortonArtivion
50
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. Nemaura Med operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 32 people. Nemaura Medical [NMRD] is a Pink Sheet which is traded between brokers as part of OTC trading. Nemaura Medical is listed under Medical Equipment category by Fama And French industry classification.

Management Performance

Nemaura Medical Leadership Team

Elected by the shareholders, the Nemaura Medical's board of directors comprises two types of representatives: Nemaura Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nemaura. The board's role is to monitor Nemaura Medical's management team and ensure that shareholders' interests are well served. Nemaura Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nemaura Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jay Warner, Head Operations
Thomas Mortensen, Head Marketing
Dewan Chowdhury, Chairman of the Board and Presidentident, CEO
Arash Ghadar, Chief Officer
Samantha Sanders, Global Programs
Bashir Timol, Chief Director

Nemaura Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Nemaura Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Consideration for investing in Nemaura Pink Sheet

If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated